Washington, DC
Grand Hyatt Washington
May 17-18, 2018


8:30am - 9:00am
Networking Breakfast and Badge Pick Up
Independence Ballroom F-I

Breakfast will be served in the ballroom so make sure to stop by the sponsor tables.

9:00am - 9:05am
Welcome Remarks
Independence Ballroom F-I


9:05am - 9:45am


Healthcare's Future in Three Words: Omics. Tailored. Connected.
Independence Ballroom F-I

Over the past 30 years, Richard Milani, MD, has received acclaim for his accurate forecasts of the future of healthcare delivery, his innovations in medicine and his contributions to new technologies that will change how all of us maintain our health.

In a 2016 interview, a reporter asked Dr. Milani to describe the future of healthcare in three words. His response: Omics. Tailored. Connected.

In this opening keynote, Dr. Milani examines what’s required to drive clinical innovation and how precision and personalized medicine will shape the future of healthcare, enhancing our ability to improve health and reduce disease. And how three words will make a world of difference.

Chief Clinical Transformation Officer and Vice-Chairman of the Department of Cardiology
Ochsner Health System

9:45am - 10:20am

Leadership Panel

Precision Medicine Today & Tomorrow
Independence Ballroom F-I

Despite amazing technological breakthroughs for precision medicine, government champions, and continuing and significant investment, challenges exist related to appropriate regulatory guidelines, suitable reimbursement, and the education of healthcare professionals.

In this kick-off leadership panel, our experts discuss the current state of precision medicine and how to overcome these challenges. Additionally, they’ll address how to realistically:

  • Build on the current advancements with precision medicine technologies.
  • Streamline the process to clinical practice and make precision medicine easily understandable to the general public.
  • Make sure precision medicine and individualized treatments are available for all patients in need.
Chief Technology Officer,Oncology Informatics and Genomics
Philips Healthcare
Director of Operational Integration
Inova Genomics Laboratory
Director of Payer and Life Sciences
Chair, Department of Radiology Oncology
Thomas Jefferson University
Chief Clinical Transformation Officer and Vice-Chairman of the Department of Cardiology
Ochsner Health System

10:20am - 10:50am
Networking Break
Independence Ballroom F-I

Take this opportunity to mingle with your peers in a relaxed setting to build relationships and establish future partnerships. Coffee will be served in the ballroom so make sure to stop by our sponsor tables.

10:50am - 11:20am

Million Veteran Program

A Mega Cohort, Big Data, and Scaling Clinical Applications
Independence Ballroom F-I

The VA’s Million Veteran Program has collected genetic data on close to 700,000 veterans and is well on its way to one million. The program’s goal: To use this vast data repository to discover new ways of preventing and treating illness in veterans – and the general public.

In this session, the program's principal investigator Michael Gaziano, MD, a Harvard professor, preventative cardiologist and internationally recognized diseased epidemiologist, discusses cohort selection, how he and his colleagues are using high-powered analytics to study the MVP data, and, importantly, how they are turning that data into knowledge.

Principal investigator, Million Veteran Program
U.S. Department of Veterans Affairs

11:20am - 11:50pm

Lessons Learned

Bridging Knowledge and Practice Gaps
Independence Ballroom F-I

Research and innovation in personalized medicine are surging. However, adoption of personalized medicine technologies into clinical practice is comparatively slow.

This presentation will provide an overview of challenges to integrating personalized medicine into health care practice and discuss different strategies for clinical implementation including: Proposing a framework for addressing clinical adoption challenges,

  • Building and disseminating the evidence of value,
  • Developing partnerships that can help ensure appropriate uptake and access to clinical testing services,
  • Educating the workforce and community,
  • Promoting data interoperability, and developing system-wide care process models.
Senior Vice President, Science Policy
Personalized Medicine Coalition

11:50am - 12:20pm

AI &Collaboration

The Precision Medicine Journey
Independence Ballroom F-I

Evolving technology in precision medicine combined with conventional treatment therapies have transformed modern medicine, helping clinicians maximize patient outcomes. But though advancements in biotechnology hold incredible promise, precision medicine’s emergence is not without programmatic challenges that inhibit the ability for both doctors and patients to take full advantage of its application and benefits.

Over the past 18 months, Dr. Douglas Reding, chief medical officer, Ascension Wisconsin, has led a national task force working to “enterprise” precision medicine practices across the health system. Dr. Reding will speak to the critical infrastructure components for implementation on this scale, the need for artificial intelligence support and the importance in streamlining collaboration across locations for the future.

Chief Medical Officer
Ascension Wisconsin

12:20pm - 12:45pm
Speaker Hub
Independence Ballroom F-I

One of the best ways learn is to network with your peers. This session provides an opportunity for attendees to meet with morning speakers and dive deeper into specific topics.

Here's how it works:

Speakers from the morning sessions will be stationed at different tables in the room. Attendees can circulate and speak one-on-one or in groups with individual speakers.

Network, share and learn in this interactive environment.

12:45pm - 1:30pm
Networking Lunch
Independence Ballroom F-I

Take this opportunity to mingle with your peers in a relaxed setting to build relationships and establish future partnerships.

1:30pm - 2:00pm

Pathway to Innovation

A Business Model for Precision Medicine and Big Data
Independence Ballroom F-I

Efforts are underway to develop an approach to precision medicine across research, clinical and academic settings, but a gap exists in forming a comprehensive model that is rigorous enough to enable the development of comprehensive approaches to harnessing data, yet flexible enough to allow for innovation and creativity.

This session, healthcare visionary Sam Hanna describes model that is flexible, rigorous and addresses the need for structure as healthcare undergoes massive changes and embrace precision medicine

The presentation will address:

  • A comprehensive business model for precision medicine.
  • Key steps to take to develop innovations related to big data.
  • A scalable approach that entices vendors and VC firms.


Professor, Healthcare Strategy
George Washington University

2:00pm - 2:30pm

Lesson's Learned

Bringing Precision Medicine to a Community Hospital
Independence Ballroom F-I

The Gibbs Cancer and Research Institute in upstate South Carolina received a Duke Endowment Grant to initiate a precision medicine program in its community hospital setting. In this session, two of the program’s leaders will explain how they developed operational user workflows and share lessons learned in building and planning a hospital-wide initiative involving oncology, pathology, clinical lab, IT, billing, navigation, and clinical research.

As attendees will learn, precision medicine is not exclusive to academic medical centers. Community hospitals can also participate, and in this session attendees will learn what’s need to do just that.

A few things to keep in mind on the journey to precision medicine:

  • Keep it simple.
  • Go slow and stay committed.
  • Make it fun and relevant.
Molecular Director, Precision Medicine Program
Gibbs Cancer Center
Duke Endowment Grant to Gibbs Cancer Center

2:30pm - 3:00pm

Creating Interoperabilty

Scaling a Precision Medicine Program
Independence Ballroom F-I

Henry Ford Health System has implemented a clinically oriented program to scale precision cancer care to patients across our enterprise.

This session will discuss Henry Ford’s standardized precision medicine structure that extends across 15 disease sites, along with its clinical bioinformatics structure. Key to the entire program has been building a data warehouse to support data integration needs. The presentation also will walk the audience through the journey of creating interoperability amongst disparate data systems.

Key takeaways:

  • Understand how precision medicine is changing the way cancer care is delivered.
  • Define elements of a system-wide precision medicine program.
  • Identify how to create interoperability amongst data across an organization.
Director, Precision Medicine Program
Henry Ford Health System

3:00pm - 3:20pm
Networking Break
Independence Ballroom F-I

Take this opportunity to mingle with your peers in a relaxed setting to build relationships and establish future partnerships. Coffee will be served in the ballroom so make sure to stop by our sponsor tables.

3:20pm - 4:00pm

FDA & ONC Leadership Interview

Scanning the Reimbursement & Regulatory Landscape
Independence Ballroom F-I

In this session, Jeff Coughlin, HIMSS's senior director of federal & state affairs, gives a quick regulatory update, and then interviews precision medicine leaders at the ONC and FDA on the status of their departmental initiatives.

Zayas Caban
Chief Scientist
Office of the National Coordinator
Senior Staff Fellow, Personalized Medicine
U.S. Food and Drug Administration
Senior Director of Federal & State Affairs

4:00pm - 4:30pm

Featured Speaker

Ethical Issues, Access & Affordability
Independence Ballroom F-I

Precision medicine is still a young and growing field and loaded with excitement and promise, but it’s also fraught with questions that, at the moment, have no clear answers.

For example:

  • Will precision medicine increase or decrease health disparities?
  • Will a high-tech personalized approach only be available to those with means or platinum/Cadillac insurance plans?
  • Will having a certain genetic subtype of a disease increase or decrease stigmatization of the disease?
  • How will patient privacy and confidentiality be maintained?

In this session, a leading bioethicist from the Cleveland Clinic addresses these and other questions related to ethics, access, and affordability head on.

Director of the Center for Bioethics
Cleveland Clinic Foundation

4:30pm - 4:35pm
End-of-Day Remarks
Independence Ballroom F-I


4:35pm - 5:35pm
Networking Reception
Independence Ballroom F-I

After a day of informative and incisive presentations, enjoy a drink and hors d'oeuvres in the Grand Ballroom with your fellow attendees, speakers and sponsors.

Get Updates

Sign up to get the latest information on upcoming events.